Myriad Genetics and agency partner S50 Health educated OBGYNs and their patients in a campaign called “Getting Ahead of ...

Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and precision medicine, continues to empower parents with increased access to prenatal testing. SneakPeek, the #1 OBGYN-recommended ...

The World Bank has committed to giving Bangladesh $400 million for implementing the next five-year plan for the health sector ...

CHCH-TV started broadcasting in 1954 and is proud to be the news leader for Hamilton and the surrounding Halton and Niagara ...

Black women voters and elected officials poured their hearts and souls — and finances — into campaigning on behalf of VP Kamala Harris.

Notes from several investment houses indicate that the insurance giant will no longer cover genetic tests for behavioral health, which includes Myriad's GeneSight, beginning Jan. 1, 2025.

This is actually something I will be treating my mum to this Christmas - so if you're reading this click out now! They're ...

This is the second edition of Giant Leap’s deep dive series, where its investment team explores the technologies and approaches addressing global problems of climate, health and people with commercial ...

Stephens analyst Mason Carrico notes that Myriad Genetics (MYGN ... no longer cover multi-panel genetic tests for behavioral health diagnoses. The announcement lists codes that will be denied ...

Myriad is actively engaging with UnitedHealthcare to discuss the large body of evidence for Myriad’s proprietary and clinically differentiated mental health medication test, GeneSight, and is seeking ...

Call it Trump Tummy, Ballot Blues, Election Ute, whatever you want—people are experiencing unusual symptoms as they head to ...